myocardial infarction: Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
309 |
4. Check minimum number of eventsNone |
309 |
5. Include endpointsNone |
309 |
6. Filter based on genotype QC (FinnGen only) |
309 |
Control definitions (FinnGen only)
- Control exclude
- I9_ISCHHEART
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I20-I25
- Name in latin
- Aliquae complicationes post infarctum myocardii acutum
Similar endpoints
↥List of similar endpoints to
Complications following myocardial infarction
based on the number of shared cases.
Similar with more cases:
- Ischaemic heart disease, wide definition
- Ischemic heart diseases
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4502 | 1945 | 2459 |
| Only index persons | 2275 | 934 | 1341 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.07 |
| Only index persons | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 74.10 | 77.64 | 71.22 |
| Only index persons | 72.79 | 77.27 | 69.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 309 | 83 | 226 |
| Unadjusted period prevalence (%) | 0.08 | 0.03 | 0.10 |
| Median age at first event (years) | 71.35 | 72.11 | 71.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 276
- Matched controls
- 2758
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I23.0
ICD-10 Finland
Haemopericardium as current complication following acute myocardial infarction
+∞
172.6
147
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
135.2
105.5
108
13
I25.2
ICD-10 Finland
Old myocardial infarction
310.8
72.0
70
*
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
28.8
69.3
96
50
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
15.3
57.0
101
100
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
+∞
48.4
45
*
I21.0
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
42.8
40
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
59.2
42.4
49
10
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
+∞
41.7
39
*
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
394.6
35.8
35
*
AN1
HP
Coronary angiography
15.0
34.5
59
49
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
+∞
33.0
31
*
I21.2
ICD-10 Finland
Acute transmural myocardial infarction of other sites
+∞
30.8
29
*
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
+∞
29.7
28
*
I21.1
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
29.7
28
*
I23.8
ICD-10 Finland
Other current complications following acute myocardial infarction
+∞
29.7
28
*
I23.1
ICD-10 Finland
Atrial septal defect as current complication following acute myocardial infarction
+∞
29.7
28
*
I23.2
ICD-10 Finland
Ventricular septal defect as current complication following acute myocardial infarction
+∞
29.7
28
*
I23.6
ICD-10 Finland
Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction
+∞
28.6
27
*
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
36.2
27.6
35
11
81
HP
Angiography of the heart and coronary arteries
23.5
26.0
37
18
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
+∞
24.3
23
*
I21.01
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
23.2
22
*
C01DA14
ATC
isosorbide mononitrate; oral
6.0
23.1
69
144
I20.99
ICD-10 Finland
Angina pectoris, unspecified
249.8
23.0
23
*
I20.09
ICD-10 Finland
Unstable angina
+∞
22.2
21
*
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
+∞
21.1
20
*
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
+∞
20.0
19
*
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
+∞
20.0
19
*
I21.19
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
20.0
19
*
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
79.1
20.0
22
*
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
+∞
19.0
18
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
3.9
18.2
87
290
I21.00
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
17.9
17
*
I20.90
ICD-10 Finland
Angina pectoris, unspecified
+∞
17.9
17
*
I21.09
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
+∞
16.8
16
*
I20.00
ICD-10 Finland
Unstable angina
+∞
16.8
16
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
3.9
16.7
77
247
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
20.7
15.8
23
12
I20.01
ICD-10 Finland
Unstable angina
+∞
15.8
15
*
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
60.1
15.0
17
*
AN3
HP
Balloon angioplasty and metallic stent
+∞
14.7
14
*
11
HP
Coronary artery bypass surgery
+∞
14.7
14
*
B01AC04
ATC
clopidogrel; oral
4.5
14.7
55
144
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
20.5
14.5
21
11
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
+∞
13.6
13
*
82
HP
Single vessel balloon catheter extension
+∞
13.6
13
*
AN2
HP
Balloon angioplasty, including several vessels
+∞
12.6
12
*
AA1
HP
Conventional CABG
+∞
12.6
12
*
I21.10
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
12.6
12
*
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
16.9
12.3
19
12
FNC20
NOMESCO Finland
Aorto-coronary venous bypass with two distal anastomoses
+∞
11.5
11
*
I23.5
ICD-10 Finland
Rupture of papillary muscle as current complication following acute myocardial infarction
+∞
11.5
11
*
4100X
ICD-9 Finland
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
+∞
11.5
11
*
FXG00
NOMESCO Finland
Insertion and use of IABP
+∞
11.5
11
*
B01AA03
ATC
warfarin; systemic
2.6
11.0
98
478
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
114.1
10.5
11
*
I21.11
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
+∞
10.5
10
*
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
57.0
9.7
11
*
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
103.4
9.5
10
*
FHA20
NOMESCO Finland
Closure of VSR in posteroseptal myocardial infarction
+∞
9.4
9
*
A98
ICPC
Health maint/preventive medicine
0.5
9.2
128
1811
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
+∞
8.4
8
*
AN4
HP
Balloon angioplasty and drug eluding stent
+∞
8.4
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
8.3
54
215
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.1
7.9
30
80
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
7.8
52
211
I47.2
ICD-10 Finland
Ventricular tachycardia
12.3
7.7
13
11
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
7.4
61
280
FNC30
NOMESCO Finland
Aorto-coronary venous bypass with three distal anastomoses
+∞
7.3
7
*
I23.3
ICD-10 Finland
Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
+∞
7.3
7
*
I23
ICD-10 Finland
Certain current complications following acute myocardial infarction
+∞
7.3
7
*
C08CA07
ATC
nisoldipine; oral
30.9
7.2
9
*
AP1
HP
Catheterization of the left side of the heart
20.7
7.2
10
5
I25
ICD-10 Finland
Chronic ischaemic heart disease
20.7
7.2
10
5
C09AA05
ATC
ramipril; oral
2.2
7.0
82
445
N02BE01
ATC
paracetamol; systemic, rectal
0.5
6.8
136
1809
61
HP
Catheterization and pressure measurement of the left side of the heart
23.2
6.7
9
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.2
6.4
23
59
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
+∞
6.3
6
*
AM2
HP
Surgery of infarction complication eg VSR, aneurysm, rupture of papillary muscle
+∞
6.3
6
*
B01AC24
ATC
ticagrelor; oral
+∞
6.3
6
*
C07AB02
ATC
metoprolol; systemic
2.2
6.1
69
365
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
149
2026
0.49
8.69
12.0
10.5
29.0
24.6
u/l
0.59
135
1915
159
2106
0.50
8.37
33.9
23.7
130.4
133.6
g/l
1.31
149
2033
127
1797
0.50
7.94
25.1
15.6
69.3
71.6
ml/min/173m2
0.54
106
1486
144
1951
0.51
7.77
25.4
16.4
29.2
29.4
mg/l
0.03
117
1589
157
2054
0.52
7.28
29.6
18.9
139.7
139.6
mmol/l
0.15
144
1972
158
2062
0.52
7.25
29.8
18.9
4.1
4.0
mmol/l
1.23
143
1982
29
696
0.36
6.94
2.6
3.2
1.2
0.8
ug/l
0.42
19
486
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
64
3.62
6.70
3.3
2.0
0.4
0.4
u/ml
0.25
12
33
50
924
0.45
6.29
3.5
4.7
24.3
21.8
%
0.72
25
478
57
982
0.49
5.77
3.8
4.2
0.0
0.0
estimate
0.00
13
175
57
967
0.50
5.43
5.6
5.8
0.0
0.0
estimate
—
10
178
114
1570
0.57
5.39
9.6
7.5
88.6
83.2
u/l
0.56
101
1430
57
964
0.50
5.37
3.7
4.1
0.0
0.0
estimate
0.00
13
180
142
1841
0.58
5.31
5.2
4.8
2.3
2.7
mmol/l
4.34
125
1592
142
1839
0.58
5.27
4.7
4.8
6.5
6.1
mmol/l
2.40
116
1591
37
166
2.40
5.26
3.7
2.1
7.3
4.9
ug/l
0.60
28
132
136
1772
0.58
5.05
4.8
4.3
4.2
4.5
mmol/l
3.19
122
1555
104
1449
0.57
4.95
4.6
3.9
15.9
14.6
mm/h
0.34
90
1307
134
1748
0.59
4.95
4.8
4.4
1.3
1.4
mmol/l
3.01
119
1513
130
1705
0.59
4.86
4.8
4.2
2.2
2.0
mu/l
0.28
108
1465
75
1138
0.55
4.83
3.9
5.6
2.7
3.3
ug/l
0.42
60
980
139
1790
0.59
4.81
6.8
6.3
44.1
40.8
mmol/mol
2.43
124
1589
45
769
0.51
4.17
3.7
4.6
—
—
—
0
0
111
1481
0.61
4.15
29.6
19.9
14.4
14.0
%
1.74
104
1435
133
1691
0.63
3.96
4.4
3.9
1.4
1.3
mmol/l
1.61
118
1447
129
1650
0.63
3.93
26.1
17.5
38.4
38.2
%
0.07
71
1006
56
851
0.58
3.33
4.7
3.5
—
—
—
0
0
54
814
0.59
3.08
2.7
2.1
75.7
76.4
nmol/l
0.07
46
682
34
577
0.54
2.97
1.8
1.6
14.0
20.2
nmol/l
3.02
28
467
41
658
0.57
2.94
4.7
3.4
0.3
0.6
e6/l
0.65
29
501
85
1128
0.66
2.69
3.0
3.2
137.7
56.4
u/l
1.00
70
1026
65
912
0.64
2.68
7.3
4.1
—
—
—
0
0
104
1323
0.68
2.64
4.2
3.5
15.3
15.2
pmol/l
0.15
83
1134
80
1067
0.66
2.57
7.0
6.4
11.9
12.6
umol/l
0.26
75
991
82
1088
0.66
2.56
11.0
8.9
4.7
4.5
e9/l
0.47
69
931
62
870
0.64
2.53
3.0
2.4
—
—
—
0
0
34
547
0.57
2.43
3.3
4.3
0.0
0.0
estimate
0.00
11
165
100
1251
0.70
2.19
7.0
4.1
7.7
6.8
mmol/l
1.36
94
1177
72
955
0.68
2.17
2.0
2.1
91.7
91.9
pmol/l
0.02
40
489
11
43
2.62
2.12
3.3
1.7
83.5
82.3
%
0.06
11
38
33
489
0.64
1.68
3.8
3.3
2.5
2.5
mmol/l
0.09
27
421
24
382
0.60
1.65
4.4
3.3
1.2
1.5
e6/l
0.16
13
229
77
969
0.73
1.64
5.9
4.3
33.1
34.3
g/l
0.99
67
885
90
1103
0.74
1.61
10.5
5.6
1.2
1.2
mmol/l
0.64
72
903
25
388
0.61
1.56
4.1
3.1
0.7
1.2
e6/l
1.02
13
233
83
1007
0.76
1.33
9.3
5.0
1.2
1.2
mmol/l
0.99
74
880
61
768
0.74
1.27
3.0
3.2
2.3
2.3
mmol/l
0.01
51
645
40
507
0.76
0.87
1.7
1.8
400000391.3
14214890.2
pmol/l
0.46
31
401
42
528
0.76
0.86
3.5
2.8
13017.3
10790.2
umol/l
0.06
34
433
15
225
0.65
0.85
1.3
1.3
1.2
19.3
u/ml
—
6
71
0
24
0.00
0.79
0.0
1.1
—
309.8
—
0
12
8
48
1.68
0.79
3.4
2.1
3.6
3.9
g/l
—
8
43
19
263
0.70
0.73
2.1
4.6
9.7
61.7
ug/l
0.98
14
219
7
40
1.77
0.71
1.9
1.4
—
—
—
0
0
84
732
1.20
0.71
4.0
2.9
2106.9
1929.0
ng/l
0.16
74
612
41
503
0.79
0.71
3.9
2.6
—
—
—
0
0
53
631
0.81
0.71
2.7
2.0
243.0
354.7
u/l
0.40
48
590
7
41
1.72
0.70
1.3
1.5
—
—
—
0
0
46
381
1.24
0.64
43.7
27.2
2.2
1.5
inr
—
7
43
26
201
1.32
0.61
5.2
3.2
1.4
1.8
mmol/l
0.18
15
145
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
16
116
1.40
0.55
14.1
7.4
23.5
24.8
mmol/l
1.07
16
116
46
388
1.22
0.55
6.8
2.9
3399.1
355.7
ng/l
0.90
39
327
67
758
0.85
0.53
3.3
2.3
137.1
180.6
ug/l
1.03
58
669
14
103
1.38
0.46
2.1
2.5
1.4
1.2
%
0.21
14
103
13
172
0.75
0.42
1.9
2.1
13.5
12.5
nmol/l
0.12
13
149
29
241
1.22
0.42
10.6
6.0
0.3
1.3
mmol/l
0.59
19
184
0
15
0.00
0.41
0.0
1.3
—
7.7
—
0
8
0
15
0.00
0.41
0.0
4.5
—
90.0
—
0
15
0
17
0.00
0.41
0.0
1.0
—
440.6
—
0
7
0
17
0.00
0.41
0.0
1.1
—
44.2
—
0
6
7
103
0.67
0.40
1.0
1.3
—
—
—
0
0
20
247
0.80
0.39
2.9
3.8
—
—
—
0
0
49
547
0.88
0.33
2.1
1.8
1283.7
1183.8
nmol/l
0.30
36
397
6
89
0.67
0.33
3.2
3.1
—
—
—
0
0
7
53
1.33
0.31
1.1
1.6
—
—
—
0
0
7
54
1.30
0.30
1.1
1.6
—
—
—
0
0
24
280
0.85
0.29
2.0
1.7
—
—
—
0
0
13
161
0.80
0.28
1.5
1.2
—
—
—
0
0
27
310
0.86
0.27
3.1
1.9
2.2
2.2
g/l
0.04
22
275
14
113
1.25
0.27
2.3
1.8
—
—
—
0
0
8
67
1.20
0.26
1.4
1.3
—
—
—
0
0
28
245
1.16
0.25
10.8
5.9
4.9
5.1
kpa
0.92
23
231
28
246
1.15
0.24
10.8
5.9
11.6
11.6
kpa
0.02
23
234
5
40
1.25
0.22
1.0
1.7
—
—
—
0
0
5
41
1.22
0.22
1.6
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
922.8
—
0
11
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
4.8
—
—
—
0
0
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
16
137
1.18
0.19
4.3
4.1
-0.1
1.5
mmol/l
—
7
100
8
68
1.18
0.16
1.4
1.3
—
—
—
0
0
23
207
1.12
0.15
1.6
2.3
66.4
65.5
g/l
0.23
18
176
84
874
0.95
0.14
4.5
3.4
264.4
30.5
ng/l
1.32
61
664
8
99
0.80
0.14
1.5
2.1
—
—
—
0
0
26
282
0.91
0.12
2.0
1.7
—
—
—
0
0
12
136
0.88
0.11
1.6
1.4
—
—
—
0
0
31
330
0.93
0.10
1.3
1.2
0.6
0.9
u/ml
—
9
80
15
165
0.90
0.09
2.1
1.6
—
—
—
0
0
27
287
0.94
0.08
3.0
1.9
21.1
23.1
%
0.39
20
246
10
88
1.14
0.08
1.3
1.2
—
—
—
0
0
19
176
1.08
0.07
1.6
1.7
—
—
—
0
0
59
571
1.04
0.07
2.4
2.0
3.4
3.1
mg/l
0.38
43
470
7
83
0.84
0.07
2.1
1.7
—
—
—
0
0
12
109
1.10
0.06
4.3
3.9
44.7
46.8
%
0.10
12
109
14
151
0.92
0.05
2.4
2.8
62.7
56.7
ml/min/173m2
—
9
60
29
280
1.04
0.03
9.7
7.6
—
—
—
0
0
11
103
1.07
0.02
2.6
1.7
—
—
—
0
0
40
393
1.02
0.01
1.9
1.6
2.3
1.6
mg/l
0.40
32
308
15
148
1.01
0.00
1.7
1.8
1.5
1.7
%
0.64
15
123
42
418
1.01
0.00
2.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
157.6
—
0
5
0
5
0.00
0.00
0.0
3.4
—
13.7
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
5
55
0.91
0.00
1.6
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
59
0.84
0.00
1.8
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
5
55
0.91
0.00
1.6
1.4
—
—
—
0
0
8
81
0.99
0.00
1.4
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
8.1
—
0
7
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_MI_COMPLICATIONS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_MI_COMPLICATIONS | 2.357 [1.88, 2.95] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.801 |
During the follow-up period (1.1.1998 — 31.12.2019), 329 out of 499 females with I9_MI_COMPLICATIONS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_MI_COMPLICATIONS | 2.412 [1.98, 2.93] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 427 out of 704 males with I9_MI_COMPLICATIONS died.
Mortality risk
Mortality risk for people of age
years, who have I9_MI_COMPLICATIONS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.256% | 0.471% |
| 5 | 1.612% | 2.737% |
| 10 | 4.016% | 6.797% |
| 15 | 7.708% | 13.221% |
| 20 | 13.262% | 21.439% |
Relationships between endpoints
↥Index endpoint: I9_MI_COMPLICATIONS – Complications following myocardial infarction
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data